Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Each increase in dosage produced approximately 3 additional percentage points of weight loss
Studied in central-nervous-s
Sheng K, Yang J, Xu Y, et al
It is possible that people with a history of eating disorders are more likely to be attracted to this form of eating, which may enhance their preoccupation with food
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand names Ozempic and Rybelsus), chronic weight management (Wegovy), and cardiovascular risk reduction in specific populations
US$ 20.86
US$ 25.30
US$ 23.37
US$ 27.35
US$ 27.35
